Enhancing Patient Experience of Pain and Sleep Through Non-Pharmacological Strategies
Launched by METHODIST HEALTH SYSTEM · Jun 9, 2020
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aim(s)/Objective(s)
* Improve patient sleep during their hospital stay.
* Determine patient self-reported pain assessment using non-pharmacologic strategies.
* Determine if the "patient toolkit" improves patient experience of pain and sleep.
Hypothesis 1. Primary Hypothesis Patients' experience of pain and sleep will improve with the implementation of interventions from our "patient toolkit".
.2. Secondary Hypothesis Patients will report an increase in sleep and a decrease in pain after use of the interventions provided in the "patient toolkit".
3. Tertiary Hypothesis Patients will repo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Hospitals eligible to participate will meet the following criteria:
- • Part of the MHS (MCMC, MDMC, MMMC, MRMC)
- • The hospital has at least one clinical site/sub-investigator on-staff
- • Hospital has 150 or more inpatient beds
- Patients eligible to participate will meet the following criteria:
- • Any patient admitted to the study units (MDMC: 10ST; MCMC: A6; MMMC: A3; MRMC: 3Medical ) that do not have any of the exclusion criteria described below
- • Age: 20+ y/o
- • Must be able to speak/read/write/understand English
- • Willing to utilize study interventions and complete survey booklet
- Exclusion Criteria:
- • Hospitals outside of MHS will be excluded.
- Patients will be excluded for the following reasons:
- • Patients admitted for surgical procedure
- • Change in clinical status and deterioration requiring higher level care
- • Altered mental status
- • Any history of dementia and/or Alzheimer's
- • Disoriented/confused
- • Patients suffering with chronic pain
- • Patients on patient-controlled analgesia
- • Observation status patients
About Methodist Health System
Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Laura Sweatt, MSN, RN
Principal Investigator
Methodist Health System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials